Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T-Cell Lymphoma Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00310128
What this trial is testing

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Who this might be right for
AIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell Lymphoma
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07180771
What this trial is testing

Bosmolisib (BR101801) in Participants With R/R PTCL.

Who this might be right for
Peripheral T Cell Lymphoma
Boryung Pharmaceutical Co., Ltd 44
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Early research (Phase 1)Temporarily pausedNCT04828174
What this trial is testing

Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies

Who this might be right for
Peripheral T Cell LymphomaAngioimmunoblastic T-cell LymphomaAnaplastic Lymphoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Not applicableNo Longer AvailableNCT05131438
What this trial is testing

An Expanded Access Program to Provide Sugemalimab for the Treatment of Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (R/R ENKTL)

Who this might be right for
Extranodal NK/T-cell Lymphoma
EQRx International, Inc.
Testing effectiveness (Phase 2)Study completedNCT00644189
What this trial is testing

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaMantle Cell Lymphoma+7 more
Massachusetts General Hospital 50
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Testing effectiveness (Phase 2)WithdrawnNCT02961816
What this trial is testing

Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05883449
What this trial is testing

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma
Affimed GmbH 25
Testing effectiveness (Phase 2)UnknownNCT01307592
What this trial is testing

Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Auxilio Mutuo Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03052933
What this trial is testing

Copanlisib and Gemcitabine in Relapsed/Refractory PTCL

Who this might be right for
Mature T-Cell and NK-Cell Neoplasm
Chonnam National University Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT00914940
What this trial is testing

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT06151106
What this trial is testing

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaRefractory T-Cell Lymphoma
The First Affiliated Hospital of Xiamen University 33
Early research (Phase 1)UnknownNCT03921879
What this trial is testing

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Who this might be right for
LymphomaLymphoma, Non-HodgkinLymphoma, B-Cell+4 more
Oncotartis, Inc. 50
Early research (Phase 1)Study completedNCT01871675
What this trial is testing

Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies

Who this might be right for
LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+1 more
SCRI Development Innovations, LLC 48
Early research (Phase 1)Ended earlyNCT02663518
What this trial is testing

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Who this might be right for
Hematologic MalignanciesSolid Tumor
Pfizer 249
Early research (Phase 1)UnknownNCT05387226
What this trial is testing

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
T-cell LymphomaVirusIntravenous Injection
The First Affiliated Hospital of Bengbu Medical University 6
Testing effectiveness (Phase 2)Study completedNCT02676778
What this trial is testing

Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell Lymphoma
Eisai Co., Ltd. 45
Next Page